Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other Non-Current Assets (2016 - 2025)

Lisata Therapeutics filings provide 13 years of Other Non-Current Assets readings, the most recent being $23000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets fell 85.62% year-over-year to $23000.0, compared with a TTM value of $23000.0 through Dec 2025, down 85.62%, and an annual FY2025 reading of $23000.0, down 85.62% over the prior year.
  • Other Non-Current Assets hit $23000.0 in Q4 2025 for Lisata Therapeutics, roughly flat from $23000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $449000.0 in Q1 2023, with the low at $23000.0 in Q3 2025.
  • Median Other Non-Current Assets over the past 3 years was $223500.0 (2024), compared with a mean of $224250.0.
  • The sharpest move saw Other Non-Current Assets crashed 35.41% in 2024, then tumbled 88.56% in 2025.
  • Year by year, Other Non-Current Assets stood at $332000.0 in 2023, then tumbled by 51.81% to $160000.0 in 2024, then crashed by 85.62% to $23000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $23000.0, $23000.0, and $70000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.